Illumina closes $7.1 billion deal for cancer test maker Grail amid regulatory hurdles

Illumina Inc has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc, it said on Wednesday amid challenges …
(Orginal – Story lesen…)